Not Signed In - Aida Pharmaceuticals' Researchers Meet To Formally Begin Phase II Trials Of Anti-Cancer Treatment
Fri, 16 Feb 2007 08:00 AM EST
... Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA), one of mainland China's leading pharmaceutical companies, today announced the Company's subsidiary, Shanghai Qiaer Biotechnology, held a meeting on February 10, 2007 with affiliated research hospitals and scientists to formally begin the large-scale Phase II trials of Rh-Apo2L throughout mainland China. [click link for full article] ...
Related Topics
- Clinical Trials
- Wrinkles
- Prostate Cancer
- Treatment
- Aging Skin
- Kidney Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Stomach Cancer
- Bladder Cancer
- Uterine Cancer
- Treatments
- Cancers
- Head and Neck Cancer
- Rectal Cancer
- The signs and symptoms related to the central nervous system may be irreversible if treatment is not begun within 6 months of when these symptoms begin.
- Cervical Cancer
- Brain Cancer
- Lung Cancer
- Testicular Cancer
email this page
print this page
bookmark this page
feedback on this page
